Track topics on Twitter Track topics that are important to you
bmj;360/mar21_23/k1297/FAF1faGeorge Mackie was consultant radiologist in Wolverhampton from 1971 to 2009. His career was one of innovation in a district general hospital, large volume high quality...
bmj;360/mar21_25/k1306/FAF1faYasmeen Moin (“Yaz”) was born to Mohammed Abdul and Tabassum Moin, both doctors. Growing up in Nuneaton, she attended King Henry VIII School in Coventry. She had a close...
bmj;360/mar21_26/k1307/FAF1faAlina Teresa Piesowicz was born in Warsaw in 1935. She spent her childhood in Poland during the war years before coming to England as a refugee shortly after the war...
To say patient data is a contentious topic is putting it mildly. On 15 January Public Health England (PHE) faced a barrage of media disapproval for releasing data on nearly 180 000 patients with lung...
Although President Donald Trump does not seem to have any cognitive deficits,1 he should be made aware of the brain’s susceptibility to neurodegeneration and decline in cognitive function with age....
If I’d had my heart attack in the 1950s, I would have stayed in the hospital for a month. Today, heart attack survivors can be back home in 3-5 days.Going homeI couldn’t wait to go home, to sleep in...
The rule of threeRandomised trials of new drugs are designed to detect benefits, and they’re always underpowered to detect adverse events. One consequence is that the balance of benefit and harm...
bmj;360/mar21_18/k1304/FAF1faDavid John Dickson (“John”) was born in Nunthorpe on the outskirts of Middlesbrough, Teesside, the second of four children. His father was a surgeon born in Fife and his...
bmj;360/mar21_19/k1294/FAF1faChristopher Thomas Blaiklock (“Chris”) intended to be a physician and passed the MRCP before changing his mind and training as a surgeon. He was a registrar in...
Abortion rates have declined globally over the past 25 years according to a comprehensive new report, although most of the change has occurred in developed regions with no significant change...
The number of healthcare data breach incidents continues to remain steady, and in February’s Breach Barometer report from Protenus, it was revealed that last month, a ransomware attack was responsible for the largest single incident.
The associations representing the UK’s pharma and biotech industries have announced their support of the recently published findings of the new Health and Social Care Committee report into Brexit.
Having more nursing staff educated to degree level providing treatment is linked to better outcomes in surgical patients with dementia, according to US researchers.
Imaging with FDG PET/CT may identify children and young adult osteosarcoma patients who may experience good outcomes.
A recent phase III study revealed a benefit with pacritinib for patients with myelofibrosis and thrombocytopenia who have experienced treatment failure with previous therapies.
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a positive opinion to Akcea Therapeutics’ volanesorsen for the treatment of familial chylomicronaemia syndrome (FCS) under the Early Access to Medicines Scheme (EAMS).
Keep a mental list of people who can help you, and then strive to be the go-to person for everyone else.
The FDA is granting Priority Review for the expanded use of enzalutamide in nonmetastatic castration-resistant prostate cancer.
Let’s head off to the outer limits of current imaging technology. Two recent papers do exactly that, and I’m going to propose combining them for even more instrumental craziness. The first covers a class of cellular structure that I had no idea even existed, even though it’s been studied for many years: bacterial gas vesicles.
China Premier Li Keqiang plans to eliminate import taxes on cancer drugs and significantly lower those for other medicines.
NewsNew data from one of the largest prospective ongoing global studies examining the use of oral antithrombotics for stroke prevention in atrial fibrillation (AF) in clinical practice, GLORIATM-AF, were presented at the EHRA 2018. The registry examined two-year safety and effectiveness outcomes of nearly 5,000 AF patients treated with dabigatran (marketed as Pradaxa).
NewsRoche announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival and demonstrated that the combination of TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane [albumin-bound paclitaxel; nab-paclitaxel]) reduced the risk of disease worsening or death compared with chemotherapy alone in the initial (first-line) treatment of people with ...
NewsThe U.S. Food and Drug Administration today approved Adcetris (brentuximab vedotin) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy.
A doctor speaks, a biotech stock tanks. What happened at this invite-only health care investor conference?
Editorial pages highlight these health topics and others.